| Dr Maxwell Eric Tolan, MD | |
|
426 Airport Rd, Hazle Township, PA 18202-3361 | |
| (570) 459-9730 | |
| Not Available |
| Full Name | Dr Maxwell Eric Tolan |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 9 Years |
| Location | 426 Airport Rd, Hazle Township, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366821274 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MT209727 (Pennsylvania) | Secondary |
| 207Q00000X | Family Medicine | MD462282 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Maylath Valley Health Systems, Inc. | Sybertsville, PA | Home health agency |
| All Care Home Care, Inc | Hazleton, PA | Home health agency |
| Geisinger Medical Center | Danville, PA | Hospital |
| Geisinger Wyoming Valley Medical Center | Wilkes barre, PA | Hospital |
| Lehigh Valley Hospital - Hazleton | Hazleton, PA | Hospital |
| Geisinger-bloomsburg Hospital | Bloomsburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Caring Community Health Center | 5698004588 | 28 |
News Archive
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
Results from a clinical trial published today in the Journal of Pediatrics show infants who consume formula containing milk fat globule membrane (MFGM) - a complex layer that normally surrounds fat in milk - score higher in tests of cognitive, language and motor development by their first birthdays than infants consuming a milk-based formula that didn't contain MFGM.
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."
Exiqon A/S today published data from a clinical study that stratifies colon cancer patients into groups of high, medium and low chances of survival which may prove useful for optimizing the treatment of each individual cancer patient.
› Verified 8 days ago
| Entity Name | Berwick Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184793127 PECOS PAC ID: 0648279620 Enrollment ID: O20061221000093 |
News Archive
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
Results from a clinical trial published today in the Journal of Pediatrics show infants who consume formula containing milk fat globule membrane (MFGM) - a complex layer that normally surrounds fat in milk - score higher in tests of cognitive, language and motor development by their first birthdays than infants consuming a milk-based formula that didn't contain MFGM.
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."
Exiqon A/S today published data from a clinical study that stratifies colon cancer patients into groups of high, medium and low chances of survival which may prove useful for optimizing the treatment of each individual cancer patient.
› Verified 8 days ago
| Entity Name | Caring Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679038293 PECOS PAC ID: 5698004588 Enrollment ID: O20190830001893 |
News Archive
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
Results from a clinical trial published today in the Journal of Pediatrics show infants who consume formula containing milk fat globule membrane (MFGM) - a complex layer that normally surrounds fat in milk - score higher in tests of cognitive, language and motor development by their first birthdays than infants consuming a milk-based formula that didn't contain MFGM.
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."
Exiqon A/S today published data from a clinical study that stratifies colon cancer patients into groups of high, medium and low chances of survival which may prove useful for optimizing the treatment of each individual cancer patient.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Maxwell Eric Tolan, MD 100 N Academy Ave, Danville, PA 17822-4903 Ph: (570) 271-6144 | Dr Maxwell Eric Tolan, MD 426 Airport Rd, Hazle Township, PA 18202-3361 Ph: (570) 459-9730 |
News Archive
QuatRx Pharmaceuticals Company, a privately-held biopharmaceutical company, today announced positive efficacy results from the second of two patient cohorts in the second pivotal Phase 3 study for Ophena(TM) (ospemifene tablets), the company's investigational compound in development for the treatment of postmenopausal vulvovaginal atrophy (VVA).
Results from a clinical trial published today in the Journal of Pediatrics show infants who consume formula containing milk fat globule membrane (MFGM) - a complex layer that normally surrounds fat in milk - score higher in tests of cognitive, language and motor development by their first birthdays than infants consuming a milk-based formula that didn't contain MFGM.
In this Toronto Star opinion piece, Richard Elliott, executive director of the Canadian HIV/AIDS Legal Network, and Nicci Stein, executive director of the Interagency Coalition on AIDS and Development, discuss how progress made in the fight against HIV/AIDS over the last 30 years "is in peril, due to governments reneging on repeated promises to fund the fight against the pandemic."
Exiqon A/S today published data from a clinical study that stratifies colon cancer patients into groups of high, medium and low chances of survival which may prove useful for optimizing the treatment of each individual cancer patient.
› Verified 8 days ago
Mr. John Ogrodnick, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 26 Station Cir, Hazle Township, PA 18202 Phone: 570-501-6800 | |
Megan L Ferderber, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 26 Station Cir, Hazle Township, PA 18202 Phone: 570-861-8710 Fax: 570-497-4046 | |
Dr. Anand Prasad Sewak, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 426 Airport Rd, Hazle Township, PA 18202 Phone: 570-459-9730 |